X-linked agammaglobulinemia (XLA) is a symptomatic primary antibody deficiency (PAD) caused by mutations in the Bruton’s tyrosine kinase (BTK) gene located on the long arm of X-chromosome encoding the cytoplasmic BTK [1, 2]. This evidence concerns the gene BTK and peripheral arterial disease.